BR:NYSEBroadridge Financial Solutions, Inc. Analysis
Data as of 2026-03-10 - not real-time
$186.63
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Broadridge posted $7.18 B in revenue with a 7.8% YoY increase and lifted FY'26 adjusted EPS guidance to 9‑12%, underscoring solid top‑line momentum. Trailing EPS of $9.03 and a forward EPS of $10.35 reflect a healthy earnings trajectory, while a ROE of 41.8% and free cash flow of $1.20 B highlight strong cash generation. The stock trades at a P/E of 20.7, well below the industry average of 36.8, and the DCF model suggests a fair value around $173, implying modest upside to current levels but significant upside to analyst targets (median $247.5). Technicals show the price ($186.63) above the 20‑day SMA (180.8) but below the 50‑day (198.6) and 200‑day (229.1) averages, with a neutral RSI (47.7) and a bullish MACD histogram (+2.52), suggesting short‑term resilience amid a broader bearish medium‑term trend.
Recent material news adds a growth catalyst: a partnership with Crypto.com to route crypto orders through the NYFIX platform and the Distributed Ledger Repo (DLR) platform processing $365 B daily, expanding Broadridge’s foothold in digital assets. The dividend remains attractive at 2.06% with a 41% payout ratio, supported by robust cash flows. Overall, the blend of earnings strength, strategic digital‑asset expansion, and a valuation gap relative to peers positions BR as a compelling buy for medium to long horizons, while short‑term traders should respect the bearish medium‑term bias and decreasing volume.
Recent material news adds a growth catalyst: a partnership with Crypto.com to route crypto orders through the NYFIX platform and the Distributed Ledger Repo (DLR) platform processing $365 B daily, expanding Broadridge’s foothold in digital assets. The dividend remains attractive at 2.06% with a 41% payout ratio, supported by robust cash flows. Overall, the blend of earnings strength, strategic digital‑asset expansion, and a valuation gap relative to peers positions BR as a compelling buy for medium to long horizons, while short‑term traders should respect the bearish medium‑term bias and decreasing volume.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 50‑day SMA and near resistance at $197.38
- Decreasing volume and high 30‑day volatility (41%)
- Attractive dividend yield and solid cash flow
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Raised FY'26 EPS outlook and 9‑12% growth guidance
- Strategic digital‑asset partnership with Crypto.com and expanding DLR platform
- Undervalued multiple vs industry peers and strong ROE
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend supported by free cash flow
- High ROE (41.8%) and consistent operating cash generation
- Long‑term secular demand for fintech and tokenization services
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin14.86%
P/E Ratio20.7
ROE41.79%
ROA9.18%
Debt/Equity117.17
P/B Ratio7.6
Op. Cash Flow$1.4B
Free Cash Flow$1.2B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI47.7
Support$163.71
Resistance$197.38
MA 20$180.79
MA 50$198.63
MA 200$229.10
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$173.00
Target Price$245.88
Upside/Downside31.74%
GradeUndervalued
TypeBlend
Dividend Yield2.06%
Risk Assessment
Beta0.51
Volatility41.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.